Potential of telomerase activation in extending health span and longevity

Current Opinion in Cell Biology

Volumn 24, Issue 6, 2012, Pages 739-743

  de Jesus, Bruno Bernardes ^a   Blasco, Maria A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGS 499; DNA; NEUROPROTECTIVE AGENT; TELOMERASE; UNCLASSIFIED DRUG;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; DNA DAMAGE; DNA MODIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; LIFESPAN; LONGEVITY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TRANSGENIC MOUSE;

AGING; ANIMALS; DISEASE; DNA DAMAGE; ENZYME ACTIVATION; HEALTH; HUMANS; LONGEVITY; REJUVENATION; TELOMERASE;

EID: 84871938321     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2012.09.004     Document Type: Review

References (56)

1. Moslehi J., Depinho R.A., Sahin E. Telomeres and mitochondria in the aging heart. Circ Res 2012, 110:1226-1237.
2. Vijg J., Campisi J. Puzzles, promises and a cure for ageing. Nature 2008, 454:1065-1071.
3. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 2005, 120:449-460.
4. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
5. Hao L.Y., Armanios M., Strong M.A., Karim B., Feldser D.M., Huso D., Greider C.W. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 2005, 123:1121-1131.
6. Armanios M., Alder J.K., Parry E.M., Karim B., Strong M.A., Greider C.W. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet 2009, 85:823-832.
7. Collado M., Blasco M.A., Serrano M. Cellular senescence in cancer and aging. Cell 2007, 130:223-233.
8. de Jesus B.B., Blasco M.A. Assessing cell and organ senescence biomarkers. Circ Res 2012, 111:97-109.
9. DePinho R.A. The age of cancer. Nature 2000, 408:248-254.
10. Greenberg R.A., Chin L., Femino A., Lee K.H., Gottlieb G.J., Singer R.H., Greider C.W., DePinho R.A. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 1999, 97:515-525.
11. Feldser D.M., Greider C.W. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 2007, 11:461-469.
12. Begus-Nahrmann Y., Hartmann D., Kraus J., Eshraghi P., Scheffold A., Grieb M., Rasche V., Schirmacher P., Lee H.W., Kestler H.A., et al. Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. J Clin Invest 2012, 122:2283-2288.
13. Ding Z., Wu C.J., Jaskelioff M., Ivanova E., Kost-Alimova M., Protopopov A., Chu G.C., Wang G., Lu X., Labrot E.S., et al. Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell 2012, 148:896-907.
14. Matheu A., Maraver A., Klatt P., Flores I., Garcia-Cao I., Borras C., Flores J.M., Vina J., Blasco M.A., Serrano M. Delayed ageing through damage protection by the Arf/p53 pathway. Nature 2007, 448:375-379.
15. Serrano M., Blasco M.A. Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol 2007, 8:715-722.
16. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., Kirkland J.L., van Deursen J.M. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236.
17. Herranz D., Munoz-Martin M., Canamero M., Mulero F., Martinez-Pastor B., Fernandez-Capetillo O., Serrano M. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 2010, 1:1-8.
18. Ortega-Molina A., Efeyan A., Lopez-Guadamillas E., Munoz-Martin M., Gomez-Lopez G., Canamero M., Mulero F., Pastor J., Martinez S., Romanos E., et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab 2012, 15:382-394.
19. Garcia-Cao I., Song M.S., Hobbs R.M., Laurent G., Giorgi C., de Boer V.C., Anastasiou D., Ito K., Sasaki A.T., Rameh L., et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 2012, 149:49-62.
20. Sahin E., Colla S., Liesa M., Moslehi J., Muller F.L., Guo M., Cooper M., Kotton D., Fabian A.J., Walkey C., et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011, 470:359-365.
21. de Jesus B.B., Vera E., Schneeberger K., Tejera A.M., Ayuso E., Bosch F., Blasco M.A. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 2012, 4:1-14.
22. Tomas-Loba A., Flores I., Fernandez-Marcos P.J., Cayuela M.L., Maraver A., Tejera A., Borras C., Matheu A., Klatt P., Flores J.M., et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 2008, 135:609-622.
23. Gonzalez-Suarez E., Samper E., Ramirez A., Flores J.M., Martin-Caballero J., Jorcano J.L., Blasco M.A. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 2001, 20:2619-2630.
24. Blackburn E.H. Structure and function of telomeres. Nature 1991, 350:569-573.
25. Blasco M.A. Telomere length, stem cells and aging. Nat Chem Biol 2007, 3:640-649.
26. Jiang H., Ju Z., Rudolph K.L. Telomere shortening and ageing. Z Gerontol Geriatr 2007, 40:314-324.
27. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004, 101:17312-17315.
28. Canela A., Vera E., Klatt P., Blasco M.A. High-throughput telomere length quantification by FISH and its application to human population studies. Proc Natl Acad Sci USA 2007, 104:5300-5305.
29. Flores I., Cayuela M.L., Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 2005, 309:1253-1256.
30. Mitchell J.R., Wood E., Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999, 402:551-555.
31. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001, 413:432-435.
32. Sacco A., Mourkioti F., Tran R., Choi J., Llewellyn M., Kraft P., Shkreli M., Delp S., Pomerantz J.H., Artandi S.E., et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 143:1059-1071.
33. Parry E.M., Alder J.K., Qi X., Chen J.J., Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 2011, 117:5607-5611.
34. Blasco M.A. Telomeres in cancer and aging: lessons from the mouse. Cancer Lett 2003, 194:183-188.
35. Martinez P., Thanasoula M., Munoz P., Liao C., Tejera A., McNees C., Flores J.M., Fernandez-Capetillo O., Tarsounas M., Blasco M.A. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 2009, 23:2060-2075.
36. Tejera A.M., Stagno d'Alcontres M., Thanasoula M., Marion R.M., Martinez P., Liao C., Flores J.M., Tarsounas M., Blasco M.A. TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev Cell 2010, 18:775-789.
37. Flores I., Canela A., Vera E., Tejera A., Cotsarelis G., Blasco M.A. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev 2008, 22:654-667.
38. Beier F., Foronda M., Martinez P., Blasco M.A. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of Dyskeratosis congenita. Blood 2012, 10.1182/blood-2012-03-418038.
39. Korbling M., Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept?. N Engl J Med 2003, 349:570-582.
40. Jung P., Sato T., Merlos-Suarez A., Barriga F.M., Iglesias M., Rossell D., Auer H., Gallardo M., Blasco M.A., Sancho E., et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med 2011, 17:1225-1227.
41. Ruzankina Y., Pinzon-Guzman C., Asare A., Ong T., Pontano L., Cotsarelis G., Zediak V.P., Velez M., Bhandoola A., Brown E.J. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007, 1:113-126.
42. Strong M.A., Vidal-Cardenas S.L., Karim B., Yu H., Guo N., Greider C.W. Phenotypes in mTERT+/- and mTERT-/- mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase. Mol Cell Biol 2011, 31:2369-2379.
43. Heidinger B.J., Blount J.D., Boner W., Griffiths K., Metcalfe N.B., Monaghan P. Telomere length in early life predicts lifespan. Proc Natl Acad Sci USA 2012, 109:1743-1748.
44. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005, 6:611-622.
45. Gonzalez-Suarez E., Geserick C., Flores J.M., Blasco M.A. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 2005, 24:2256-2270.
46. Park J.I., Venteicher A.S., Hong J.Y., Choi J., Jun S., Shkreli M., Chang W., Meng Z., Cheung P., Ji H., et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009, 460:66-72.
47. Greider C.W. Molecular biology. Wnt regulates TERT-putting the horse before the cart. Science 2012, 336:1519-1520.
48. Sachsinger J., Gonzalez-Suarez E., Samper E., Heicappell R., Muller M., Blasco M.A. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells. Cancer Res 2001, 61:5580-5586.
49. Jaskelioff M., Muller F.L., Paik J.H., Thomas E., Jiang S., Adams A.C., Sahin E., Kost-Alimova M., Protopopov A., Cadinanos J., et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469:102-106.
50. Gonzalez-Suarez E., Samper E., Flores J.M., Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 2000, 26:114-117.
51. Fauce S.R., Jamieson B.D., Chin A.C., Mitsuyasu R.T., Parish S.T., Ng H.L., Kitchen C.M., Yang O.O., Harley C.B., Effros R.B. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol 2008, 181:7400-7406.
52. de Jesus B.B., Schneeberger K., Vera E., Tejera A., Harley C.B., Blasco M.A. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 2011, 10:604-621.
53. Harley C.B., Liu W., Blasco M., Vera E., Andrews W.H., Briggs L.A., Raffaele J.M. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res 2011, 14:45-56.
54. Eitan E., Tichon A., Gazit A., Gitler D., Slavin S., Priel E. Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol Med 2012, 4:313-329.
55. Sahin E., Depinho R.A. Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol 2012, 13:397-404.
56. Vera E., de Jesus B.B., Foronda M., Blasco M.A. The Rate of increase of short telomeres predicts longevity in mammals. Cell Rep 2012, 10.1016/j.celrep.2012.08.023.